How does leuprolide therapy affect erythropoiesis in patients with anemia, and what implications does this have for managing hematological health during treatment?
Gaurav ChauhanContributor
How does leuprolide therapy affect erythropoiesis in patients with anemia?
Share
Leuprolide may exacerbate anemia by suppressing erythropoiesis, suggesting the need for close monitoring of red blood cell levels during treatment.
Leuprolide therapy can reduce erythropoietin production, potentially worsening anemia in patients; hematological assessments are crucial.
In patients using leuprolide, decreased erythropoiesis might lead to anemia, requiring strategies like supplemental iron or erythropoietin administration.